Henrijette Richter Ph.D Overview
- Firm
- Sofinnova Partne...
- Primary Position
-
Managing Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
8
- Med. Deal Size
-
- Med. Valuation
-
Henrijette Richter Ph.D General Information
Biography
Dr. Henrijette Richter serves as Managing Partner at Sofinnova Partners. She serves as Vice-Chairman of the Supervisory Board at iOmx Therapeutics. She serves as Board Member at Mozart Therapeutics and Nitrase Therapeutics. Previously, she served as a Partner in the company. She serves as Board Member at Comet Therapeutics,Freya Biosciences, Orphazyme ApS, CytoGuide ApS, Karolinska Development, Delinia, and MycoTeQ A/S (as chairman). She is the Director of Scientific Analysis with Sunstone Capital and an Investment Analyst in Vaekstfondens Life Science Ventures group. A Postdoctoral fellow at Massachusetts Institute of Technology (MIT), Center for Cancer Research. Ph.D. and Industrial Scientist degree in Molecular Biology from the University of Copenhagen. She is a Board Member of Avilex Pharma. She also serves as Board Member at NodThera. She serves as Board Member at Muna Therapeutics.
Contact Information
Address
- 7-11 Boulevard Haussmann
- 75009 Paris
- France
Henrijette Richter Ph.D Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
iOmx Therapeutics | Company | Vice-Chairman of Supervisory Board | Munich, Germany | Drug Discovery | |
Sofinnova Partners | Investor | Managing Partner | Paris, France | Venture Capital |
Henrijette Richter Ph.D Board Seats (9)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Asceneuron | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Lausanne, Switzerland | |
Comet Therapeutics | Drug Discovery | Acquired/Merged | Formerly VC-backed | Cambridge, MA | |
Freya Biosciences | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Copenhagen, Denmark | |
iOmx Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Munich, Germany | |
Mozart Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Seattle, WA |
Henrijette Richter Ph.D Lead Partner on Deals (22)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Asceneuron | 16-Jul-2024 | Later Stage VC (Series C) | Completed | Drug Discovery | Lausanne, Switzerland | |
Freya Biosciences | 12-Dec-2023 | Completed | Biotechnology | Copenhagen, Denmark | ||
Mozart Therapeutics | 07-Jun-2023 | Completed | Drug Discovery | Seattle, WA | ||
Redona Therapeutics | 16-Jun-2022 | Completed | Drug Discovery | Watertown, MA | ||
Nitrase Therapeutics | 02-Nov-2021 | Completed | Drug Discovery | Brisbane, CA | ||
iOmx Therapeutics | 05-Oct-2021 | Completed | Drug Discovery | Munich, Germany | ||
Muna Therapeutics | 09-Jul-2021 | Completed | Drug Discovery | Copenhagen, Denmark | ||
NodThera | 22-May-2020 | Completed | Drug Discovery | Boston, MA | ||
Comet Therapeutics | 13-Jun-2019 | Early Stage VC (Series A1) | Completed | Drug Discovery | Cambridge, MA | |
Comet Therapeutics | 05-Nov-2018 | Seed Round | Completed | Drug Discovery | Cambridge, MA |
Henrijette Richter Ph.D Network (304)
Board Members (139)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Nick Haft | Freya Biosciences | OMX Ventures | Copenhagen, Denmark | |
Rita Balice-Gordon Ph.D | Muna Therapeutics | Muna Therapeutics | Copenhagen, Denmark | |
Karolinska Development | Self | Solna, Sweden | ||
Nitrase Therapeutics | Self | Brisbane, CA | ||
Strategic Partners. | EQT Life Sciences | Herlev, Denmark |
Portfolio Executives (118)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
J. Michael Ryan MD | Asceneuron | Chief Medical Officer | 16-Jul-2024 | Lausanne, Switzerland |
Dirk Beher Ph.D | Asceneuron | Co-Founder, Chief Executive Officer & Board Member | 16-Jul-2024 | Lausanne, Switzerland |
Asceneuron | Co-Founder, Chief Operating Officer & Vice President, Research & Development | 16-Jul-2024 | Lausanne, Switzerland | |
Asceneuron | Senior Director & Head of Preclinical Development | 16-Jul-2024 | Lausanne, Switzerland | |
Asceneuron | Consultant - Head of Non-Clinical Development and Medicinal Chemistry | 16-Jul-2024 | Lausanne, Switzerland |
Fund Team Members (47)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Maina Bhaman | Sofinnova Partners | Sofinnova Capital VIII | Paris, France |
Maina Bhaman | Sofinnova Partners | Sofinnova Capital IX | Paris, France |
Sofinnova Partners | Paris, France | ||
Sofinnova Partners | Paris, France | ||
Sofinnova Partners | Paris, France |
Henrijette Richter Ph.D Affiliated Funds (7)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Novo Ventures 1 | Novo Holdings | Venture - General | Closed | 2013 | ||||
Novo Seeds | Novo Holdings | Venture Capital - Early Stage | Evergreen | |||||
Sofinnova MD Start III Fund | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2020 | ||||
Sofinnova Capital IX | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2020 | ||||
Sofinnova Capital VII | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2012 |
Henrijette Richter Ph.D FAQs
-
Who is Henrijette Richter Ph.D?
Dr. Henrijette Richter serves as Managing Partner at Sofinnova Partners.
-
How much does Henrijette Richter Ph.D typically invest?
Henrijette Richter Ph.D's median deal size is
. -
What is Henrijette Richter Ph.D’s main position?
Henrijette Richter Ph.D’s primary position is Managing Partner.
-
What are the contact details for Henrijette Richter Ph.D?
Henrijette Richter Ph.D’s email address is hr
and his phone number is +33 01 . -
How many active board seats does Henrijette Richter Ph.D hold?
Henrijette Richter Ph.D holds 9 board seats including Asceneuron, Comet Therapeutics, Freya Biosciences, iOmx Therapeutics, and Mozart Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »